An experimental weight loss drug’s side effects have Roche stock tumbling

Roche

In This Story RHHBY TERN Roche stock slid Monday morning after a conference poster highlighted data regarding the side effects patients experienced during an early-stage trial of its experimental weight loss drug. Suggested Reading A GameStop stock winner wants a JetBlue board seat Meta rejected Donald Trump's claim that Mark Zuckerberg is ditching Democrats in 2024 Air Canada is getting ready to suspend operations as a pilot strike looms Nvidia stock is navigating one of its most turbulent

Tag-uri: Roche Donald Trump

din zilele anterioare